| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |